In the first week of October 2020, Edelweiss Asset Management Ltd (EAML) announced a partnership with MSCI Inc, a leading provider of critical decision support tools and services for the global investment community, to launch Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund. This launch marks MSCI’s foray into the Indian market. The NFO will be open from 6 October 2020 to 20 October 2020. First in a series of collaborations between Edelweiss and MSCI, the thematic passive index fund is designed to provide Indian investors undiluted access to invest in top healthcare companies from India and around the world. “We are pleased to partner with MSCI, a global leader in indices, which has a proven track record of strong governance and robust processes,” says Radhika Gupta, MD & CEO, EAML. “This partnership with MSCI is consistent with Edelweiss AMC’s legacy of building strong and sustainable alliances, much like the one with JP Morgan in 2016 and, more recently, with the government of India on the Bharat Bond ETF, India’s first corporate bond, launched in 2019”. EAML is a part of the investment & advisory business of Edelweiss Group and remains one of the fastest growing and youngest AMCs in India, with an AUM of Rs40,400 crore as on 31 August 2020. Poised for growth “We believe that this fund will provide investors with an easy, low-cost and undiluted access to promising healthcare companies in India and around the world,” says Gupta. “Given the rise in lifestyle diseases and the uptick in spending to treat them, the healthcare sector is primed to grow steadily over the next decade,” adds she.
-
Gupta: building strong alliances
